James Crowe Archive — Page 12 of 13
-
July 19, 2012
Long antibodies better against HIV
Understanding how antibodies with long “loops” form may be important for HIV vaccine development. -
April 27, 2012
Dengue antibodies give vaccine leads
New information may help speed development of a vaccine or treatment for dengue fever. -
April 12, 2012
Targeting post-transplant diabetes
Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes. -
February 15, 2012
On the tail of RSV infection mechanism
New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly. -
October 7, 2011
Diversity key in antibody repertoire
Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines. -
January 6, 2011
Aliquots – VUMC research highlights
-
June 17, 2008
$2.4 million NIH grant puts Children’s Hospital researcher at forefront of new direction in HIV research
After recent efforts to develop a vaccine to protect against AIDS proved ineffective, the National Institutes of Health announced a change in research direction; and it\'s one that will involve the lab of James Crowe, M.D., professor of Pediatrics, Microbiology and Immunology at the Monroe Carell Jr. Children\'s Hospital at Vanderbilt.